EJE Rising Stars
The 2024 EJE Rising Star Award is presented to individuals selected by the EJE Editors as showing exceptional promise, achievement and trajectory in establishing themselves as independent leading clinical and translational endocrine researchers, with high potential to serve as future editors of EJE. The awards consists of membership of the EJE Rising Star Reviewer Board for two years, a dedicated mentorship programme for future editors of EJE and a travel bursary for attendance at ECE and the EJE Editorial Board meeting.
Here is a list of 2024’s awardees.
Barbara Altieri
University Hospital of Würzburg, Germany
Dr Barbara Altieri works as Clinician Scientist at the Endocrinology Department of the University Hospital of Würzburg, Germany. She completed her MD and the Endocrinology Training at the Catholic University of Sacred Heart, Rome, Italy, where she obtained the PhD in Nutrition, Metabolism, Aging, and Gender Diseases together with the Doctor Europaeus qualification.
Her scientific interest mainly related to adrenal and neuroendocrine tumours, with particular focus on pathogenesis of adrenocortical tumours and translational aspects in adrenocortical carcinoma and Cushing Syndrome. She has published more than 85 peer-reviewed articles and has received several awards for her researcher activity, including the ESE Young Investigator Award in 2022.
Barbara is actively involved in the education of young endocrinologists as board member of the EYES (ESE Young Endocrinologists & Scientists) Committee, and she chaired the 10th EYES Annual Meeting that took place in Würzburg in September 2023. She is also member of the ACC working group Scientific Board of the European Network for the Study of Adrenal Tumours (ENS@T).
Marta Araujo-Castro
Ramón y Cajal University Hospital, Spain
Marta Araujo-Castro MD., PhD. is a Consultant Physician in the Neuroendocrinology & Adrenal Unit of the Endocrinology and Nutrition Department of the Ramón y Cajal University Hospital in Madrid, Spain. Dra. Araujo-Castro´s clinical focus and research is on pituitary and adrenal gland disorders and neuroendocrine tumors. She is the principal investigator and coordinator of the SPAIN-ALDO Register of the Spanish Society of Endocrinology & Nutrition (SEEN) and of the PHEO-PARA-RISK Study of the SEEN. Furthermore, in the last years she has received several awards related to adrenal and pituitary disorders (Cushing´s syndrome, acromegaly, adrenal incidentalomas, pheochromocytomas and so on).
Marta Araujo-Castro is the coordinator of the adrenal diseases group of the SEEN, a member of the scientific board of the working group of Aldosterone Producing Adenomas (APA) of ENSAT, coordinator of the Pituitary Committee of the Ramón y Cajal University Hospital and the principal investigator of the group of Endocrine-Metabolic, Digestive and Nutrition Surgery of the Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS). In addition, she is a member of the SEEN, the European Society of Endocrinology (ESE), Endocrine Society, Spanish Group of Neuroendocrine Tumors (GETNE), European Network for the Study of Adrenal Tumors (ENSAT), European Society of Hypertension (ESH) and a reviewer of several indexed international journals. She actively participates in several national and international congress with presentations related to adrenal and pituitary pathology. Moreover, Dra. Araujo-Castro is a professor of the master’s degree in Endocrine Oncology Pathology at TECH University; she holds the title of master’s degree in research Methodology in Health Sciences of the Laboratory of Applied Statistics of the Autonomous University of Barcelona (UAB) (Spain) and the Diploma in Statistics in Health Sciences of the UAB.
Cihan Atila
University Hospital Basel Dept. of Clinical Research, Switzerland
Dr Cihan Atila studied medicine at the Universities of Tübingen and Greifswald in Germany, as well as the University of Aberdeen in Scotland, UK. Following his graduation, he completed this MD-PhD in Clinical Research at the University of Basel, where he is currently working as a resident in the Department of Internal Medicine and a post-doctoral researcher in the Department of Endocrinology. Specializing in water- and electrolyte disturbances, Dr. Atila is keenly interested in disorders of the posterior pituitary. His current focus lies in exploring novel diagnostic and therapeutic strategies for vasopressin- and oxytocinergic dysfunctions. He has led, participated, and is experienced in experimental-translational clinical studies but also larger randomized-controlled multicenter trials. He is currently a board member of the European Neuroendocrine Association (ENEA) Young Researcher Committee (EYRC) and has garnered recognition for his contributions, receiving prestigious accolades such as the Young Talents in Clinical Research Grants from the Swiss Academy of Medical Sciences, the Rising Star Award at ENDO 2023, and the David L. Kleinberg Early Career Pituitary Investigator Prize from the Pituitary Society in recent years.
Anna Aulinas
Hospital de Sant Pau, Barcelona, Spain
I am Anna Aulinas, I was born in a small town in the north of Catalonia. I graduated in Medicine from the University of Barcelona and completed my clinical training in endocrinology at the Hospital de Sant Pau in Barcelona. After completing this training in endocrinology, I obtained a technical Degree in Statistics in the Health Sciences and pursued a PhD in Medicine, working with an internationally known clinical research group in Barcelona led by Prof. Susan Webb focused on pituitary diseases. To foster my career as a clinical researcher and driven by the intention to contribute to developing new solutions to improve clinical outcomes in patients with pituitary diseases, I obtained a competitive postdoctoral fellowship, a unique opportunity that allowed me to acquire highly specialized training in clinical research from experts in neuroendocrinology in the Neuroendocrine Unit at Massachusetts General Hospital in Boston. After my Postdoctoral stay in Boston, I was awarded a highly competitive personal four-year grant from the Spanish Government in the State Program for the Promotion of Talent and Employability that allowed me to develop an independent research program investigating hypothalamic-pituitary diseases while working as a clinical endocrinologist at the Hospital de Sant Pau in Barcelona. I am currently a member of the CIBERER Unit 747 (Research Network for Rare Diseases in Spain) and the coordinator of the Pituitary Disease Unit in the Hospital de Sant Pau, an accredited National Reference Center on Pituitary Diseases and a recognized center by the European Reference Network on Rare Endocrine Diseases (EndoERN). I was appointed as an Associate Professor at the University of Vic – Central University of Catalonia (2020) and I am co-responsible for teaching and developing a research program in endocrinology & nutrition at the Faculty of Medicine and Health Sciences. I have been awarded several young investigator awards from National and International Scientific societies for my research and contributions to the field of neuroendocrinology.
Nicole Bechmann
Institute of Clinical Chemistry and Laboratory Medicine University Hospital Carl Gustav Carus, Germany
Nicole Bechmann is a molecular biologist with a strong interest in endocrinology. After her diploma in food chemistry (2011), she completed her doctorate in the field of radiobiology at the Helmholtz-Zentrum Dresden-Rossendorf (2015). After a postdoctoral fellowship at the University Hospital Carl Gustav Carus Dresden and the German Institute of Human Nutrition, she was promoted as group leader of the Department of Neurochemistry at the University Hospital Carl Gustav Carus Dresden (2023). Her research focuses on the molecular and metabolic characterization of adrenal tumors, in particular pheochromocytomas and paragangliomas, and the development of new therapeutic approaches for these rare diseases. Her particular emphasis lies on alterations in the hypoxia signaling pathway, catecholamine metabolism and the investigation of sex-specific molecular and metabolic differences. She is member of the scientific advisory board of CRC/TRR 205 "The Adrenal: Central Relay in Health and Disease" and of the advisory board of the section "Adrenal Gland, Steroids and Hypertension" of the German Society of Endocrinology as well as the coordinator of the Young Scientist Program of the CRC/TRR 205. She has already been awarded with the Bruno-Allolio Prize of the German Society for Endocrinology (2021) and the COVID-19 education award, HAVARD T.H. CHAN, School of Public Health, USA (2020) and several travel awards. She has published more than 75 peer-reviewed articles.
Mirela-Diana Ilie
Cancer Research Center of Lyon (CRCL), France
Dr Ilie is an internationally trained clinician-scientist, currently finishing her PhD at the Lyon 1 University, France. Her clinical and translational research focuses mainly on the biological and clinical implications of the pituitary tumor microenvironment, and on aggressive pituitary tumors and carcinomas. Dr Ilie has been invited to speak on these topics at several international meetings and has published so far 26 articles on pituitary tumors, 19 of which as first or last author in the best journals in the field. In addition, she is taking part in the European Endocrinology Research Roadmap/EndoCompass project of the European Society of Endocrinology as member of the Pituitary and Neuroendocrinology group. Dr Ilie serves as a reviewer for several journals and is actively involved with endocrinology-related societies. The most important roles in this regard are her being a board member of the European Neuroendocrine Association (ENEA) Young Researcher Committee and an ENEA ExCo representative. Dr Ilie has also received several national and international awards, including the Future European Endocrine Leader Award of the European Union of Medical Specialists (UEMS), Section and Board of Endocrinology, the Best Publication Award of the French Society of Endocrinology, and awards for the Best Clinical and Basic Posters at the ENEA Congress and Workshop.
Ljiljana Marina
Faculty of Medicine, University of Belgrade, Serbia
Dr. Ljiljana Marina works as an Associate Professor of Internal Medicine, at the National Centre for Infertility and Endocrinology of Gender, Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Centre of Serbia. Her focus areas are in the Adrenal and Reproductive Endocrinology. Dr. Marina has been actively involved in the work of the ESE Young Endocrinologists and Scientists (EYES). As the committee member and for the last two years an EYES co-chair, Dr. Marina founded the EYES Newsletter and the EYES Observership Program and served as the member of the European Society of Endocrinology Executive Committee. She is a member of the ESE Adrenal and Cardiovascular Endocrinology Focus Area’s Expert Panel. Dr. Marina is also a member of the Serbian Medical Society, Serbian Society for Menopause, European Network for the Study of Adrenal Tumors (ENS@T), COST ACTION Harmonis@tion and one of the founders of the Serbian Society for Adrenal Diseases and Cardiometabolic Endocrinology.
Andrea Palermo
Unit of Endocrinology and Diabetes Campus Bio-Medico University, Rome, Italy
Dr. Andrea Palermo is an endocrinologist/diabetologist at University Campus Bio-Medico, Rome, Italy. He graduated cum laude in July 2006 from University Campus Bio-Medico where he earned his M.D. During his specialization, he combined his clinical training as a diabetologist with the study of novel non-injectable insulin formulations such as the buccal spray insulin. Successively, he began his PhD course in the field of Endocrinology at the same institution. During this time, he established the basis for his future research. In particular, he focused his research interests on the interplay between bone and glucose metabolism and the study of calcium and bone metabolism, investigating new diagnostics and therapeutic aspects of clinical and subclinical forms of parathyroid glands diseases. During his PhD program, he also attended The Academic Unit of Bone Metabolism (Sheffield, UK) directed by Prof Richard Eastell where he successfully studied the normocalcemic Hypoparathyroidism and its potential genetic impairment. He has won awards for his research at national and international meetings. In particular, he received the young investigator award from the American Society of Bone and Mineral Research and Endocrine society and ECTS lain T Boyle award 2020 for the study of hypoparathyroidism. He had published more than 120 papers on parathyroid gland diseases, diabetes and thyroid disorders. Moreover, he is senior Academic Editor of “Endocrine Connections” Journal.
Alessandro Prete
Institute of Metabolism and Systems Research University of Birmingham, United Kingdom
Alessandro Prete is a Clinical Associate Professor of Endocrinology at the Institute of Metabolism and Systems Research, University of Birmingham, UK. He obtained his PhD from the same University in 2022 and is also a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, UK. Alessandro's area of research focuses on adrenal tumours, endocrine hypertension, and adrenal insufficiency, combining clinical trials and experimental medicine studies. As well as receiving awards at both national and international conferences for his work, Alessandro has over 30 peer-reviewed publications.
Carmelo Quarta
Bordeaux Neurocampus, University of Bordeaux, France
Dr Quarta is a Principal Investigator at the French National Institute of Health (Inserm). His research focuses on elucidating the neuroendocrine mechanisms that regulate food intake and systemic metabolism. His work also includes the preclinical development of innovative pharmacological interventions for obesity and diabetes. Dr Quarta is the coordinator of several national and international research grants, including an ERC Consolidator Grant. He has received 2 Young Investigator Awards from the European Society of Endocrinology (2019 and 2012) and the German Centre for Diabetes Research (DZD) Award (2017).
Julie Refardt
Erasmus MC Rotterdam Department of Internal Medicine, Section Endocrinology, Netherlands
Julie Refardt, MD PhD, is a clinical researcher, working at the department of Endocrinology at the Erasmus Medical Center in Rotterdam, the Netherlands. She studied medicine in Basel, Switzerland and did her MD in the year 2009 at the University of Basel. In 2015 she finished her specialization in internal medicine, followed by her specialization in endocrinology in 2017. In 2013 she started her career as a clinical researcher in the research team of Prof. Mirjam Christ-Crain, conducting investigator-initiated clinical trials in the field of water sodium disturbances which resulted in several high impact publications in the field of AVP-deficiency and hyponatremia. In 2019 she decided to broaden her research horizon and spent two years in one of the top European Centers for Neuroendocrine Tumors, the Erasmus Medical Center in Rotterdam, the Netherlands. After a short stay back in Switzerland, she returned to the Netherlands in 2023, where she obtained her PhD in September 2023 at the Erasmus University and started her work as a staff member and clinical researcher in October 2023 at the Erasmus Medical Center in Rotterdam. With a passion for neuroendocrinology, her research focuses on improving the diagnosis and treatment of patients with neuroendocrine disorders.
Joanna Spencer-Segal
Michigan Neuroscience Institute University of Michigan, USA
Joanna Spencer-Segal received her MD from Weill Cornell Medical College and PhD from the Rockefeller University in New York City as part of the Tri-Institutional MD-PhD program. She completed postgraduate clinical and research training in internal medicine and endocrinology at the University of Michigan, and in the Michigan Neuroscience Institute. Dr. Spencer-Segal is currently Assistant Professor of Internal Medicine and Research Assistant Professor in the Michigan Neuroscience Institute. Her laboratory studies central mechanisms of hypothalamic-pituitary-adrenal axis control, glucocorticoid signaling in critical illness, and systemic hormone regulation of motivated behaviors. Dr. Spencer-Segal also provides endocrine care for patients with pituitary tumors as part of the Multidisciplinary Pituitary Program, and she is the PI on multiple clinical trials of novel therapeutics for functional pituitary tumors.
Giampaolo Trivellin
Department of Biomedical Sciences Humanitas University, Italy
My research activity focuses on the study of genetic defects causing tumors in the pituitary gland, specifically those leading to gigantism in children and acromegaly in adults. This line of study originated during my PhD in Padova, Italy, in the laboratory of Prof. Carla Scaroni. It continued through my first post-doctoral experience in Prof. Marta Korbonits’s lab at Queen Mary University of London, UK. Subsequently, I joined Dr. Constantine Stratakis’s lab at the National Institutes of Health in the USA. In 2014, while in his lab, I identified a new gene— an orphan receptor named GPR101— involved in the most extreme cases of infantile-onset pituitary gigantism. Following this discovery, my work focused on identifying GPR101 ligands and understanding how this receptor regulates children’s growth, utilizing transgenic zebrafish models and cell lines that I developed.
In 2020, I started a junior investigatorship (Marie Curie fellowship) at the Humanitas Research Hospital in Milan, Italy. In 2021, I received a grant from the Italian Telethon Foundation for research on rare genetic diseases, enabling me to continue my research for the next three years. My current independent research interest is to functionally characterize GPR101 by dissecting the epigenetic mechanisms controlling its transcriptional regulation in normal and tumor pituitary cells. Additionally, I aim to quantify the intracellular effects elicited by newly discovered GPR101 inhibitors. Since December 2022, I have held the position of Assistant Professor of Medical Genetics at Humanitas University.
2022 Awardees
Avivit Cahn, MD
Hadassah Hebrew University Hospital, Jerusalem, Israel
Avivit Cahn graduated from the Hebrew University and completed her residency and fellowship at the Hadassah Hebrew University Hospital, where she is a practicing endocrinologist. Professor Cahn has led and participated in multiple clinical trials, including SAVOR-TIMI 53, and DECLARE-TIMI-58. She has led multiple sub-analyses of these studies including analysis of safety outcomes and outcomes in the elderly in the DECLARE-TIMI-58. Research interests include big data and digital health, monogenic diabetes and diabetic foot complications, and she has published extensively on these topics as well. She is currently the Head of the Israeli Diabetic Foot and Wound Healing Society. Professor Cahn has authored over 80 publications and book chapters, is a reviewer for multiple diabetes journals, and is on the editorial board of Diabetes/Metabolism Research and Reviews. She has lectured at multiple forums and served on numerous advisory boards.
Sophie Bensing, MD PhD
Karolinska Institutet, Stockholm, Sweden
Sophie Bensing is a senior lecturer in endocrinology at Karolinska Institutet and a senior consultant in internal medicine and endocrinology at the Karolinska University Hospital. Her research interests are autoimmune endocrine disorders with focus on adrenal insufficiency. Sophie has experience from clinical, experimental and epidemiological studies.
Guido Di Dalmazi, MD, PhD
Senior Assistant Professor, Unit of Endocrinology and Diabetes Prevention and Care, Department of Medical and Surgical Sciences, University of Bologna, IRCCS AOU S Orsola, Bologna, Italy
Dr Di Dalmazi's main research areas are the pathophysiology of adrenal diseases, including genetics aspects of tumorigenesis, steroidogenesis and hormone hypersecretion. He is author of 65 scientific publications in peer-reviewed scientific journals, with 29 publications as first/last author (H-index 21, source Scopus). Recently, he has received several awards for his research activity. Among them is the European Network for the Study of Adrenal Tumors (ENSAT) Award, 2014; the prestigious prize for the best adrenal research, the Bruno Allolio-Nebennieren-Preis, of the German Society of Endocrinology, in 2016; and the Young Investigator Award of the European Society of Endocrinology in 2020. During the last 4 years, he has been an invited speaker at more than 15 national and international conferences. In 2019, he received funding from the Italian Ministry of Health for a 3-year project on adrenocortical tumors and hypercortisolism (Call: Ricerca Finalizzata 2018, sezione C, Giovani Ricercatori, Change Promoting) and from the Italian Ministry of University and Research (Call: PRIN 2017).
Tim Korevaar, MD, PhD
Erasmus University Medical Center, Rotterdam, the Netherlands
Tim Korevaar is a postdoctoral fellow in endocrinology, epidemiologist and internist obstetric medicine in training at the Erasmus University Medical Center in Rotterdam, the Netherlands. His key research interest is gestational endocrinology including thyroid disease in fertility and pregnancy. Dr Korevaar is the co-founder and coordinator of the Consortium on Thyroid and Pregnancy, the co-chair of the current ATA guidelines on Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. He has been awarded previously with the Dutch Royal Academy of Sciences Early Career Award and the ESE Young Investigator Award and has published more than 100 peer-reviewed articles.
Dan Niculescu, PhD
C I Parhon National Institute of Endocrinology, Bucharest, Romania
Dan Niculescu graduated from the School of Medicine at the Carol Davila University of Medicine and Pharmacy, Bucharest, Romania, and later joined the university's Department of Endocrinology at C I Parhon National Institute of Endocrinology in Bucharest. Dr Niculescu is a member of the European Society of Endocrinology. His research focus and clinical practice is in pituitary disorders, and also thyroid and bone metabolism.
Svenja Nölting, MD, PhD
Comprehensive Cancer Center, University Hospital and University of Zurich, Switzerland
Professor Svenja Nölting is Consultant, Assistant Professor for Endocrine Tumors, Research Group Leader with a special interest in personalised therapy of (Neuro)endocrine Tumors, and joint Leader of the Endocrine and Neuroendocrine Tumor Center, Comprehensive Cancer Center Zurich, at the Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital of Zurich, USZ and University of Zurich, UZH. After she finished her medicine studies in 2008 and her doctoral thesis in 2009 at the LMU Munich, she started her training as Medical Doctor (MD) at the Medical Department II of the University Hospital of the LMU Munich. In 2010 she received a DFG (Deutsche Forschungsgemeinschaft) research grant for investigating novel targeted drugs in malignant phaeochromocytomas and paragangliomas in vitro and in vivo and held a post-doc position at Barts and the London School of Medicine (mentor Ashley Grossman), and at the NIH, Bethesda, Maryland, USA (mentor Karel Pacak) from 2010–2012, and then continued her training as MD at the Medical Departments II and IV of the University Hospital of the LMU Munich, becoming Research Group Leader in 2012. In 2020 she was appointed Assistant Professor for Endocrine Tumors at the USZ and UZH: she has obtained funding of more than one million Euros in total and has a significant publication record of original research.
Nicoleta Olarescu, MD, PhD
Oslo University Hospital, Norway
Dr Olarescu works as an endocrinologist at Oslo University hospital and a translational researcher at University of Oslo in Norway. Her research focusses on the molecular characterisation of the pituitary adenomas and finding novel biomarkers to predict the aggressiveness and recurrence or response to medical treatment. In addition, she is interested in the role of adipose tissue on glucose metabolism and cardiovascular risk in different endocrine diseases. She was a board member of the young researcher committee (EYRC) of ENEA, between 2018 and 2022, and was very proud to receive the ESE Jens Sandahl Christiansen award in 2022.
Michael O'Reilly, MBChB, PhD
Royal College of Surgeons in Ireland, and Beaumont Hospital, Dublin, Ireland
Michael O’Reilly is a Clinical Associate Professor at the Royal College of Surgeons in Ireland (RCSI) and Consultant Endocrinologist at the Beaumont Hospital, Dublin, Ireland. His research is supported by a 4-year HRB Emerging Clinician Scientist Award, as well as the Wellcome Trust. Michael’s research focuses on the role of androgens in mediating metabolic dysfunction in women with PCOS, with a specific focus on the link between 11-oxygenated androgens and skeletal muscle energy metabolism. He has a clinical specialist interest in reproductive disorders, adrenal tumours and pituitary disease. He spent 8 years at the University of Birmingham from 2011 to 2019, completing his PhD funded by the Wellcome Trust in 2015 under the supervision of Wiebke Arlt, followed by a position as Clinician Scientist at the Institute of Metabolism and Systems Research (IMSR) from 2015 to 2019.
Nadia Schoenmakers, PhD
University of Cambridge, UK
Dr Nadia Schoenmakers is a Principal Investigator and Wellcome Trust Senior Clinical Fellow at NIHR Cambridge Biomedical Research Centre. Nadia’s principal research interest lies in elucidating the genetic and environmental determinants of congenital hypothyroidism (CH), the commonest neonatal endocrine disorder, due either to failure of thyroid gland development (dysgenesis) or function (dyshormonogenesis). Central hypothyroidism, a rarer entity, is due to impaired thyrotropin (TSH) production by the pituitary gland. Nadia uses candidate gene, gene panel and whole exome sequencing technologies to identify known and novel genetic causes of CH. She then undertakes phenotyping of genetically ascertained individuals with parallel molecular and murine studies, aiming to gain new insights into thyroid biology and associated extra-thyroidal phenotypes.
Roland Stimson, PhD
University of Edinburgh, UK
Roland Stimson undertook his PhD at the University of Edinburgh investigating the regulation and dysregulation of tissue glucocorticoid metabolism in human obesity in a number of integrative physiological studies. He continued his postdoctoral research and clinical training as a clinical lecturer, exploring the mechanisms of glucocorticoid action in adipose tissue. In 2013, he was awarded an MRC Clinical Scientist fellowship investigating the role of human brown adipose tissue and its regulation by glucocorticoids. In 2018, he was awarded a Scottish Senior Clinical Academic Fellowship investigating the pathways regulating human brown adipose tissue and wider cold-induced thermogenesis. He is currently Professor of Endocrinology and honorary consultant physician at the University of Edinburgh and his lab specialises in the use of human experimental medicine studies to investigate human (patho)physiology in obesity and metabolic disease. Their current focus is on dissecting the pathways regulating energy expenditure with the goal of identifying targets amenable to therapeutic manipulation.
Elena Valassi, MD, PhD
International University of Catalonia, and Hospital Universitari Germans Trias i Pujol de Badalona, Barcelona, Spain
Elena Valassi is an Associate Professor of Endocrinology at the International University of Catalonia (UIC) and Consultant Endocrinologist at the Hospital Universitari Germans Trias i Pujol de Badalona (Barcelona, Spain). She is currently responsible for data quality and analysis of the European Registry of Cushing’s syndrome (ERCUSYN). After obtaining her medical degree and specialization in Endocrinology, she earned her PhD in Endocrinology and Metabolism from the University of Milan and completed her formation at the Reproductive Endocrine Unit and Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston. She received the 'Juan de la Cierva' postdoctoral grant from the Spanish Ministry of Economy and Competitiveness and was recently awarded two Health Care Research Fund Grant (FIS) from the Health Institute Carlos III to investigate the pathogenesis of residual myopathy and arthropathy in patients with acromegaly and Cushing’s syndrome in remission. Her major research interests include long-term physical/psychological consequences and patient-centered outcomes in pituitary diseases, musculoskeletal complications associated with cortisol and growth hormone excess, medical therapy in Cushing’s syndrome and management of pregnancy in patients with pituitary adenomas.
Dimitra Vassiliadi
Department of Endocrinology and Diabetes, Evangelismos Hospital, Athens, Greece
Dimitra Vassiliadi currently works as a Consultant Endocrinologist in the Department of Endocrinology and Diabetes of Evangelismos Hospital, Athens, Greece, a major National Expertise Centre for Rare Endocrine Diseases and part of the Endo-ERN in the areas of adrenal, pituitary, and thyroid disorders. She has long clinical experience in Cushing's Syndrome and her research interests focus on the clinical and pathophysiological aspects of adrenal and pituitary disorders, especially in relation to all forms of Cushing’s syndrome. An additional research interest relates to endocrine abnormalities in critical illness. She has authored 72 original papers and reviews in peer-reviewed journals. Dr Vassiliadi serves as a referee for several international journals, and is an active member of the European Society of Endocrinology, the Society for Endocrinology and the European Network for the Study of Adrenal Tumors (ENS@T).
Maria Yavropoulou, MD, MSc, PhD
Medical School of the National and Kapodistrian University of Athens (NKUA), Greece
Dr Maria Yavropoulou is a Senior Endocrinology Consultant at the Medical School of the National and Kapodistrian University of Athens (NKUA). Since October 2019, she has been the Deputy Head of the Center for Expertise of Rare Disorders of Calcium and Phosphate Metabolism (C.E.R.E.D) at LAIKO General Hospital of Athens, and Coordinator Quality of the Center for Expertise for Adult Langerhans Histiocytosis in the Hellenic Air Force and Veterans General Hospital of Athens. As a consultant she is actively involved in the management of all endocrine diseases in the Endocrinology Outpatient Clinic with emphasis on the rare endocrine diseases of calcium and phosphate metabolism. Her research activities focus on Bone Metabolism, Diabetes and Neuroendocrinology.
